Skip to main content

Emilio Botín and Narcís Serra visit the PCB

By 13 de September de 2005November 18th, 2020No Comments
< Back to news

Emilio Botín and Narcís Serra visit the PCB

On Tuesday 13 September, the president of the Santander Central Hispano Bank, Emilio Botín, and the president of the Caixa Catalunya Savings Bank, Narcís Serra, visited the Parc Científic de Barcelona (PCB, Barcelona Science Park). During this visit, these guests were escorted by the rector of the Universitat de Barcelona (UB, University of Barcelona), Màrius Rubiralta, the president of the UB Social Council, Juan José López-Burniol, and the director of the PCB, Fernando Albericio.

The tour included visits to several facilities of the PCB, a number of pharmaceutical enterprises and the , as well as two .

Later, the guests stopped by several laboratories that comprise the , the (Molecular Biology Institute of Barcelona) and the. The Grupo Santander contributes to the convergence of the university and the business sector through supporting Science and Technology Parks and also business incubators promoted by universities, such as that at the UAM-UCM (Madrid) (UAM-UCM Science and Technology Park). In this regard, the vistors wished to familiarize themselves with the current state of the PCB project, which is due to enter its second development phase this year. This phase will involve an enlargement of 10,000 m 2 of laboratory space, which will bring the total built surface area to 85,000 m 2. These laboratories will host the extension of the CIDEM-PCB Bioincubator and also the incorporation of new consolidated enterprises and public research laboratories, such as the enlargements of the IRB-PCB, the Nanobioengineering Laboratory of the CREBEC and the IBMB-CSIC. This second phase is expected to be completed at the end of 2008.

The enlargement of the IRB-PCB will involve the establishment of a new research programme, Translational and Applied Oncology (ATOP), which will comprise between 8 to 10 research groups. In this regard, the researcher Joan Massagué will head a new line of cancer investigation on metastasis (MetLab).